78
Participants
Start Date
October 31, 2008
Primary Completion Date
December 31, 2010
Study Completion Date
May 31, 2011
NorLeu3-A(1-7) in a gel formulation
Gel will be applied to the wound once daily for four weeks (treatment period). Gel will have either no active ingredient (placebo), 0.03% or 0.01% active ingredient.
Warren General Hospital Wound Clinic, Warren
Georgetown University Medical Center, Georgetown
Professional Education and Research Institute, Roanoke
Eastern Carolina Foot & Ankle Specialists, Greenville
Passavant Area Hospital, Jacksonville
Renaissance Hospital Dallas, Dallas
Southern Arizona VA Health Care System, Tucson
Southern Arizona Limb Salvage Alliance (SALSA), Tucson
Bay Area Footcare, Castro Valley
University of California, San Diego, San Diego
Olive View - UCLA Medical Center, Sylmar
Boston University School of Medicine, Boston
Collaborators (1)
National Institutes of Health (NIH)
NIH
Integra LifeSciences Corporation
INDUSTRY
US Biotest, Inc.
INDUSTRY